Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Cleared for Historic Study, Begins Enrolling Participants

Company receives FDA “may proceed” letter and investigational new drug (“IND”) application clearance Enrollment for Phase 1/2a trial has already started Upcoming trial is first time a psilocybin analog will be evaluated for MDD treatment Studies show psychedelic-based treatments may have potential to revolutionize mental healthcare, but few companies have assessed limitations of oral psilocybin […]

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Increases to 19 Worldwide Lightning Network Nodes as FED Working Paper Supports Bitcoin Scalability Through the Network

LQwD is leveraging the Lightning Network for BTC scalability with 19 nodes active and the goal of creating Lightning Network node access in 24 countries by the end of this financial quarter LQwD nodes include US-West, Ireland, India, Germany, Brazil, Hong Kong, Singapore, Sweden, South Korea, South Africa, Bahrain, Indonesia, Italy, Australia, Japan-Osaka, France, Canada, […]

Pro Athletes Provide Specialized Advocacy for Odyssey Health, Inc.’s (ODYY) Solution for Concussion-related Brain Injuries

CDC estimates put the incidence of athlete concussion incidents at 5 to 10 percent of players Currently, there is no FDA-approved medicinal treatment for helping people with concussion injuries Odyssey Health Inc. is a company developing a drug-device combination to treat concussion patients in the first minutes after injury Retired pro soccer and football athletes […]

DGE’s 9th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare

Aspiring medical professionals, influencers, solution providers, and executives of the pharma, biotech, medical device, and healthcare are invited to attend the 9th Advancing Women’s Leadership Skills & Opportunities In Pharma & Healthcare summit from September 19-21, 2022 in Philadelphia, PA. The DGE program focuses on the stories and insights of women executives who have reached […]

Correlate Infrastructure Partners Inc. (CIPI) Looking to Create Profitable, Scalable Distributed Energy Platforms with Letter of Intent to Acquire Leading Solar and Battery Storage Provider

Correlate Infrastructure Partners is a portfolio-scale development platform that provides energy optimization and clean energy solutions for North America CIPI recently entered into a letter of intent (“LoI”) to acquire a leading solar, battery storage, and roofing provider Correlate believes the acquisition will create an unmatched platform for community-scale distributed generation, storage, and virtual power […]

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Appoints New CFO as Latest Move to Strengthen Operations in Pursuit of Global Food Security

Global food security has suffered during recent years as the COVID-19 pandemic and international conflicts have challenged existing trade agreements and the infrastructure serving them Interruptions to infant and baby food supply chains have gained particular attention from consumers amid ongoing shortages on store shelves Plant-based foods investment company Eat Well Investment Group Inc. is […]

Friendable Inc. (FDBL) 360 Artist Platform Sees Growth in Revenue, Traffic and Interest Since January 2022, Driven by FeaturedX Service

Friendable acquired Artist Republik and FeaturedX to compliment the Fan Pass Live brand in January 2022 Since then, Friendable has continued to put focus on the newly acquired brands, paying particular attention to phase II of FeaturedX The company believes that phase II changes are contributing to a revenue increase, with total gross orders received […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.